Published in Circulation on August 05, 1997
Genes and human elite athletic performance. Hum Genet (2005) 1.28
Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 1.15
Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. Circulation (2011) 1.06
The upper limit of physiological cardiac hypertrophy in elite male and female athletes: the British experience. Eur J Appl Physiol (2004) 1.03
Genomics and genetics in the biology of adaptation to exercise. Compr Physiol (2011) 1.02
Gene-physical activity interactions: overview of human studies. Obesity (Silver Spring) (2008) 0.99
Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training. Eur J Appl Physiol (2004) 0.99
Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment. Cardiovasc Ultrasound (2010) 0.96
Association of angiotensin-converting enzyme insertion/deletion polymorphism with obesity, cardiovascular risk factors and exercise-mediated changes in Korean women. Eur J Appl Physiol (2009) 0.93
Association between ACE D allele and elite short distance swimming. Eur J Appl Physiol (2009) 0.92
Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise. J Am Geriatr Soc (2012) 0.91
Cardiac effects of anabolic steroids. Heart (2004) 0.89
Mechanisms governing the health and performance benefits of exercise. Br J Pharmacol (2013) 0.89
ACE genotype and the muscle hypertrophic and strength responses to strength training. Med Sci Sports Exerc (2008) 0.88
Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes. J Sports Sci Med (2009) 0.88
Association of genetic factors with selected measures of physical performance. Phys Ther (2006) 0.88
Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart. Heart (2006) 0.86
Genetic epidemiology of left ventricular hypertrophy. Am J Cardiovasc Dis (2012) 0.85
Angiotensin II type I receptor gene polymorphism: anthropometric and metabolic syndrome traits. J Med Genet (2005) 0.84
Association of the D allele of the angiotensin I converting enzyme polymorphism with malignant vascular injury. Mol Pathol (2002) 0.83
Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise? Physiol Rev (2016) 0.82
Echocardiographic differentiation of pathological and physiological left ventricular hypertrophy. Heart (2001) 0.81
ACE genotype may have an effect on single versus multiple set preferences in strength training. Eur J Appl Physiol (2005) 0.79
Angiotensin I converting enzyme gene polymorphism and exercise trainability in elderly women: an electrocardiological approach. J Sports Sci Med (2007) 0.79
Optimizing the benefits of exercise on physical function in older adults. PM R (2013) 0.78
Association of Angiotensin Converting Enzyme gene Polymorphism and Indian Army Triathletes Performance. Asian J Sports Med (2010) 0.78
The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype. Eur J Appl Physiol (2003) 0.78
No correlation between circulating ACE activity and VO2max or mechanical efficiency in women. Eur J Appl Physiol (2006) 0.78
The Hippo signal transduction network for exercise physiologists. J Appl Physiol (1985) (2016) 0.77
Effects of long-term physical activity on cardiac structure and function: a twin study. J Sports Sci Med (2009) 0.77
Anabolic Androgenic Steroid (AAS) Related Deaths: Autoptic, Histopathological and Toxicological Findings. Curr Neuropharmacol (2015) 0.77
Heart and athlete. J Tehran Heart Cent (2010) 0.75
Angiotensin-II blockage, muscle strength, and exercise capacity in physically independent older adults. J Phys Ther Sci (2016) 0.75
The use of Angiotensin-I converting enzyme i/d genetic polymorphism as a biomarker of athletic performance in humans. Biosensors (Basel) (2012) 0.75
The angiotensin-converting enzyme gene insertion-deletion polymorphism in a white British patient cohort with obstetric cholestasis. Obstet Med (2009) 0.75
The Association of ACE Genotypes on Cardiorespiratory Variables Related to Physical Fitness in Healthy Men. PLoS One (2016) 0.75
Gene-environment interactions and the response to exercise. Int J Exp Pathol (2000) 0.75
The acute effects of exercise and glucose ingestion on circulating angiotensin-converting enzyme in humans. Eur J Appl Physiol (2004) 0.75
Relationship between ace genotype and short duration aerobic performance development. Eur J Appl Physiol (2006) 0.75
The upper limit of physiological cardiac hypertrophy in elite male and female athletes in China. Eur J Appl Physiol (2007) 0.75
Contribution of job control and other risk factors to social variations in coronary heart disease incidence. Lancet (1997) 10.44
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest (1998) 6.76
Low job control and risk of coronary heart disease in Whitehall II (prospective cohort) study. BMJ (1997) 6.13
Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet (2000) 4.54
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation (2003) 4.48
Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med (1995) 4.37
The management of hypertrophic cardiomyopathy. N Engl J Med (1997) 4.15
Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet (2008) 3.87
Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol (1997) 3.64
Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation (2002) 3.63
Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med (1996) 3.59
Errors in the polymerase chain reaction. Nucleic Acids Res (1988) 3.52
Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing country. Neurol India (2007) 3.52
Role of auxilin in uncoating clathrin-coated vesicles. Nature (1995) 3.42
Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation (2002) 3.22
Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol (1981) 3.12
Psychosocial work characteristics and social support as predictors of SF-36 health functioning: the Whitehall II study. Psychosom Med (1998) 3.05
Prevalence of anaemia in pregnant & lactating women in India. Indian J Med Res (2006) 3.04
Side effects of long-term amiodarone therapy. Circulation (1983) 3.03
Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet (2001) 3.02
Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet (1995) 2.97
Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol (2000) 2.89
Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev (2007) 2.78
Rapid diagnosis of tuberculous meningitis by polymerase chain reaction. Lancet (1991) 2.77
Relative contribution of early life and adult socioeconomic factors to adult morbidity in the Whitehall II study. J Epidemiol Community Health (2001) 2.69
A cladistic analysis of phenotype associations with haplotypes inferred from restriction endonuclease mapping. II. The analysis of natural populations. Genetics (1988) 2.68
Socio-economic status and blood pressure: an overview analysis. J Hum Hypertens (1998) 2.68
Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol (1990) 2.67
Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A (1991) 2.53
Cardiac fatigue following prolonged endurance exercise of differing distances. Med Sci Sports Exerc (2000) 2.47
Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol (1983) 2.34
Electrocardiographic changes in 1000 highly trained junior elite athletes. Br J Sports Med (1999) 2.32
Matrix metalloproteinases and cardiovascular disease. Circ Res (1995) 2.27
Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet (1999) 2.27
Expression of inducible nitric oxide synthase in human heart failure. Circulation (1996) 2.26
Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J (1999) 2.24
Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart (2004) 2.22
Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J (1985) 2.22
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J (1997) 2.16
Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation (1997) 2.04
Measuring brain natriuretic peptide. Lancet (1996) 2.03
Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol (1998) 2.03
Is retirement good or bad for mental and physical health functioning? Whitehall II longitudinal study of civil servants. J Epidemiol Community Health (2003) 1.98
How effective are rapid access chest pain clinics? Prognosis of incident angina and non-cardiac chest pain in 8762 consecutive patients. Heart (2006) 1.98
Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart (2007) 1.97
The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem (1993) 1.94
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. Br Heart J (1981) 1.91
Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol (1990) 1.91
Kinetic studies of gene frequency. I. Use of a DNA copy of reticulocyte 9 S RNA to estimate globin gene dosage in mouse tissues. J Mol Biol (1974) 1.87
Frequency and predictors of adverse events. PRiSM Psychosis Study. 3. Br J Psychiatry (1998) 1.86
High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis. Circulation (2009) 1.83
Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ (2007) 1.81
Raised blood pressure, not renin-angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats. Cardiovasc Res (2000) 1.78
Kinetic studies of gene frequency. II. Complexity of globin complementary DNA and its hybridization characteristics. J Mol Biol (1974) 1.78
Human gene for physical performance. Nature (1998) 1.78
Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation (1999) 1.76
Mouse globin gene expression in erythroid and non-erythroid tissues. Cell (1976) 1.75
A conserved clathrin assembly motif essential for synaptic vesicle endocytosis. J Neurosci (2000) 1.75
Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol (2001) 1.74
Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation (1990) 1.73
M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction. Am J Cardiol (1980) 1.72
Translation of mouse globin messenger ribonucleic acid from which the poly(adenylic acid) sequence has been removed. Biochemistry (1974) 1.72
Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol (1999) 1.71
Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest (1994) 1.69
Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev (2003) 1.68
Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol (1993) 1.68
Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet (2001) 1.67
Are there age and sex differences in the investigation and treatment of heart failure? A population-based study. Br J Gen Pract (2000) 1.67
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart (2000) 1.66
Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol (1992) 1.66
Exercise training enhances endothelial function in young men. J Am Coll Cardiol (1999) 1.65
Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation (2001) 1.64
QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Eur Heart J (1996) 1.63
Seasonal variation in cause-specific mortality: are there high-risk groups? 25-year follow-up of civil servants from the first Whitehall study. Int J Epidemiol (2001) 1.61
Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol (1985) (1999) 1.61
Clinical significance of giant negative T waves in hypertrophic cardiomyopathy. J Am Coll Cardiol (1990) 1.60
Waiting for coronary angiography: is there a clinically ordered queue? Lancet (2000) 1.58
Homozygous mutation of desmocollin-2 in arrhythmogenic right ventricular cardiomyopathy with mild palmoplantar keratoderma and woolly hair. Cardiology (2008) 1.57
Mechanisms of exercise limitation in hypertrophic cardiomyopathy. J Am Coll Cardiol (1992) 1.57
Allele specific amplification by tetra-primer PCR. Nucleic Acids Res (1992) 1.56
Diagnostic criteria for tuberculous meningitis and their validation. Tuber Lung Dis (1994) 1.54